As the debate over pharmaceutical prices intensifies, multiple U.S. States have introduced bills in a bid to force the pharmaceutical industry to disclose costs. With drug makers fighting back, will any of the new legislation be passed? And if so, what affect will this new legislation have on pharmaceutical pricing? Read more here. (Source: Ed Silverman, The Wall Street Journal, 4/24/15)
You are here: / / Can US State Transparency Legislation Help Reduce Drug Prices?